Skip to main content

Fluidigm's Polaris

Fluidigm said this week that it will provide attendees of the Advances in Genome Biology and Technology meeting a first look at the firm's new Polaris single-cell research system. Polaris integrates cell selection, isolation, dose, culture, and molecular preparation into a single workflow. According to the firm, it will enable researchers to directly correlate gene expression with environmental conditions and phenotypic information. Fluidigm plans to begin shipping the new system mid-year.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.